Literature DB >> 28588358

Marchiafava-Bignami's Disease, as Etiologic Diagnosis of Athetosis.

Alberto Vargas Canas1,2, Mario Rivas1, Rodrigo Guerrero Torrealba1, María Francisca Fajre Caamano3.   

Abstract

The Marchiafava-Bignami disease, characterized by demyelination and necrosis of the corpus callosum, has typically been associated with chronic alcohol intake, and clinically has various symptoms and signs. However, several cases have been reported without alcohol association, and these - according to several publications - have some common points, such as preference for female, related to malnutrition, and radiological involvement of the splenium of the corpus callosum. We report a case of a patient with the characteristics described above and whose clinical manifestation was Athetosis. The authors associate this manifestation with the somatotopic distribution of the corpus callosum, and contribute to the etiologic diagnosis of Athetosis as a manifestation of the Marchiafava-Bignami disease, which has not been reported in the medical literature according to our review of the database.

Entities:  

Keywords:  Athetosis; Corpus callosum; Marchiafava-Bignami disease

Year:  2017        PMID: 28588358      PMCID: PMC5448430          DOI: 10.1159/000464424

Source DB:  PubMed          Journal:  Ann Neurosci        ISSN: 0972-7531


  11 in total

Review 1.  Clinicoradiologic subtypes of Marchiafava-Bignami disease.

Authors:  Alexander Heinrich; Uwe Runge; Alexander V Khaw
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 2.  Birth-related syndromes of athetosis and kernicterus.

Authors:  Allison Przekop; Terence D Sanger
Journal:  Handb Clin Neurol       Date:  2011

3.  Marchiafava-Bignami disease (MBD) in a nonalcoholic patient: a case report.

Authors:  Santosh B Murthy; Ali Jawaid; John E Bock; Salah U Qureshi; Paul E Schulz
Journal:  Can J Neurol Sci       Date:  2010-01       Impact factor: 2.104

4.  Non-alcoholic partially reversible marchiafava-bignami disease: review and relation with reversible splenial lesions. A case report and literature review.

Authors:  M Caulo; C Briganti; F Notturno; G Committeri; P A Mattei; A Tartaro; M Gallucci; A Uncini
Journal:  Neuroradiol J       Date:  2009-03-23

5.  Hemispheric disconnection syndrome with a "crossed avoiding" reaction in a case of Marchiafava-Bignami disease.

Authors:  B Lechevalier; J C Andersson; P Morin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-05       Impact factor: 10.154

6.  Marchiafava-Bignami disease.

Authors:  A H Koeppen; K D Barron
Journal:  Neurology       Date:  1978-03       Impact factor: 9.910

7.  Athetotic and spastic cerebral palsy: anatomic characterization based on diffusion-tensor imaging.

Authors:  Shoko Yoshida; Katsumi Hayakawa; Kenichi Oishi; Susumu Mori; Toyoko Kanda; Yuriko Yamori; Naoko Yoshida; Haruyo Hirota; Mika Iwami; Souzo Okano; Hiroko Matsushita
Journal:  Radiology       Date:  2011-05-09       Impact factor: 11.105

8.  Human motor corpus callosum: topography, somatotopy, and link between microstructure and function.

Authors:  Mathias Wahl; Birgit Lauterbach-Soon; Elke Hattingen; Patrick Jung; Oliver Singer; Steffen Volz; Johannes C Klein; Helmuth Steinmetz; Ulf Ziemann
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

Review 9.  Diagnosis and management of Marchiafava-Bignami disease: a review of CT/MRI confirmed cases.

Authors:  Matti Hillbom; Pertti Saloheimo; Shinsuke Fujioka; Zbigniew K Wszolek; Seppo Juvela; Maurizio A Leone
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-26       Impact factor: 10.154

10.  Functional topography of human corpus callosum: an FMRI mapping study.

Authors:  Mara Fabri; Gabriele Polonara
Journal:  Neural Plast       Date:  2013-02-14       Impact factor: 3.599

View more
  1 in total

1.  Marchiafava-Bignami Disease Associated with Spinal Involvement.

Authors:  Jhon Perea; María Belén Luis; Luciana Grimanesa Lázaro; Sergio Scollo; Agustina Tamargo; José Crespo; Maira Avalle; Horacio Solarz; Nora Fernández Liguori; Ricardo Alonso
Journal:  Case Rep Neurol Med       Date:  2020-10-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.